Immunotherapy efficacy can be boosted by preserving lymph nodes, crucial for T cell training. Research suggests lymph node removal during surgery may hinder cancer treatment response. Gut bacteria also influence immunotherapy.
Johns Hopkins researchers found boosting immune defenses prevents cancer recurrence and boosts survival. Activating T and B cells transforms 'cold' tumors, enhancing immunotherapy and radiation treatment effectiveness.
Research reveals immune system over-activation in spastic paraplegia type 15. Microglia changes and killer T-cells contribute to neuronal damage, suggesting potential immune-based therapies for this neurodegenerative disease.
